Trends and Disparities in the Use of Immunotherapy for Triple-Negative Breast Cancer in the US.
Trends and Disparities in the Use of Immunotherapy for Triple-Negative Breast Cancer in the US. JAMA Netw Open. 2025 Feb 03; 8(2):e2460243.
PMID: 39960669
Patient-reported upper extremity impairment following mastectomy with breast reconstruction: A systematic review.
Patient-reported upper extremity impairment following mastectomy with breast reconstruction: A systematic review. J Plast Reconstr Aesthet Surg. 2025 Apr; 103:233-247.
PMID: 40009951
Social vulnerability is associated with advanced breast cancer presentation and all-cause mortality: a retrospective cohort study.
Social vulnerability is associated with advanced breast cancer presentation and all-cause mortality: a retrospective cohort study. Breast Cancer Res. 2024 Dec 03; 26(1):176.
PMID: 39627859
Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer.
Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer. Ann Surg Oncol. 2024 Dec; 31(13):8829-8842.
PMID: 39251516
Validation of the RSClin risk calculator in the National Cancer Data Base.
Validation of the RSClin risk calculator in the National Cancer Data Base. Cancer. 2024 Apr 15; 130(8):1210-1220.
PMID: 38146744
The Importance of Parental Leave and Lactation Support for Surgeons.
The Importance of Parental Leave and Lactation Support for Surgeons. Clin Colon Rectal Surg. 2023 Sep; 36(5):333-337.
PMID: 37564351
Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients.
Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients. NPJ Breast Cancer. 2023 May 06; 9(1):33.
PMID: 37149628
Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US.
Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US. JAMA Netw Open. 2023 03 01; 6(3):e235834.
PMID: 36995711
De-Escalating Breast Cancer Therapy.
De-Escalating Breast Cancer Therapy. Surg Clin North Am. 2023 Feb; 103(1):83-92.
PMID: 36410355
ASO Visual Abstract: Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery and Those Treated With Mastectomy.
ASO Visual Abstract: Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery and Those Treated With Mastectomy. Ann Surg Oncol. 2022 Jun 05.
PMID: 35661949